Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
35.90
-1.12 (-3.03%)
Official Closing Price
Updated: 7:00 PM EST, Nov 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
35
36
Next >
New Data for AREXVY, GSK’s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease
October 25, 2023
From
GSK plc
Via
Business Wire
Bank Of America, Mastercard, NRA And Others Are Lobbying For Cannabis Banking Reform — Who Knew?
October 22, 2023
Several entities have included the Secure and Fair Enforcement Regulation (SAFER) Banking Act on their lobbying disclosures for the third quarter of 2023.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...
Via
Talk Markets
(GSK) - Analyzing GSK's Short Interest
October 09, 2023
Via
Benzinga
Price Over Earnings Overview: GSK
September 22, 2023
Via
Benzinga
How Is The Market Feeling About GSK?
September 19, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
October 28, 2023
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its...
Via
Talk Markets
3 Bill Gates Stocks to Buy for Billionaire-Like Returns
October 27, 2023
Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.
Via
InvestorPlace
3 Deeply Undervalued Growth Stocks
October 27, 2023
As in 2022, the current downturn of stocks appears to be way overdone, making this a good time to buy undervalued growth stocks.
Via
InvestorPlace
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
October 27, 2023
From
Alector, Inc.
Via
GlobeNewswire
Peering Into GSK's Recent Short Interest
October 26, 2023
Via
Benzinga
Price Over Earnings Overview: GSK
October 24, 2023
Via
Benzinga
GSK: Pharma Giant Prioritizing Shareholder Dividends
October 13, 2023
A good hunting ground for dividend stocks is often companies from which Wall Street wants to see strong performance in the short-term, while its long-term prospects are actually what are most bright.
Via
Talk Markets
Google AI-Powered Chatbot's Ethical Concerns, MGM Hackers Waited For Days Before Issuing Financial Demands, Costco Accused Of Sharing Confidential Health Data With Facebook: Today's Top Stories
October 11, 2023
Bloomberg Google's AI Dilemma - Bard's Promise Versus Ethical Concerns
Via
Benzinga
Topics
Artificial Intelligence
Hacking
Exposures
Artificial Intelligence
Information Security
Little Less Heartburn For GSK: Settles Another California Lawsuit On Zantac
October 11, 2023
GSK plc (NYSE: GSK) has reached a confidential settlement in the Cantlay/Harper case filed in California state court.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
China-Based Zhifei Biological Partners With GSK To Expand Shingrix Vaccine Access Across China Via £2.5B Deal
October 09, 2023
GSK plc (NYSE: GSK) has reached an exclus
Via
Benzinga
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
October 06, 2023
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger
Via
Benzinga
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
October 06, 2023
GSK Plc (NYSE: GSK) said it raised £885.6 million (
Via
Benzinga
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug
October 03, 2023
AstraZeneca Plc (NASDAQ: AZN) has
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
October 02, 2023
Read the latest report on NanoViricides here
Via
Benzinga
7 ‘Smart Money’ Stocks Set to Explode Higher
September 30, 2023
Invest like the pros by wagering on these top seven smart money stocks to buy at this time, offering tremendous upside ahead.
Via
InvestorPlace
Moderna's Shares Could Take Off if These 2 Things Happen
September 30, 2023
Moderna stock soared early in the pandemic.
Via
The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...
Via
Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 27, 2023
By David Willey, Benzinga
Via
TheNewswire.com
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
Read the latest report on NanoViricides here
Via
Benzinga
Why Are Antifungal Focused Scynexis Stock Plunging Today?
September 25, 2023
Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga
Via
Benzinga
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
September 25, 2023
Friday, The Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborns from severe RSV
Via
Benzinga
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
September 19, 2023
Bloomberg
Via
Benzinga
European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug
September 19, 2023
The European Commission has approved ViiV Healthcare's Apretude (cabotegravir long-acting (LA) injectable and tablets)
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
35
36
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.